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We present a case of a young woman, who was examined for polymorphic complaints.
Life-threatening complications during a standard treatment occurred, because of severe
left ventricular dysfunction caused by an incessant atrial tachycardia and subsequent
tachycardia induced cardiomyopathy. The only symptom reflecting the serious diagnosis
was a mild dyspnoea on exertion. Because of patient’s dissimulation, this symptom was
uncovered late. Focal atrial tachycardia was successfully treated with catheter ablation and
the treatment resulted in normalization of the left ventricular systolic function in three
months.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Dyspnoea is one of the most frequent symptoms presented to
the physicians. The etiology of dyspnoea is various and it is
crucial to exclude the most serious diseases that could threat
patient’s life. Cardiac etiology of dyspnoea should definitely
be excluded. In the following case-report we present a case of
a young woman with severe complications caused by her
dissimulation and late diagnosis of the cause of dyspnoea.2. Case report
An attractive 20 year old woman is entering the emergency
room of the Coronary Care Unit on Friday afternoon. Little didch Society of Cardiology.
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cnice Trˇebı´cˇ, Purkynˇovo Nshe and present physicians know that she was on very thin
edge of never leaving this room.
This woman had been completely healthy so far and she
used only transdermal hormonal contraception. Only when
asked directly about palpitations, she remembered some epi-
sodes of irregular heart beat since childhood. She did not really
mind these palpitations, although they had recently been
coupled with slight dyspnoea, she had been sensing them only
in horizontal position. She had been examined at surgery
outpatient department because of epigastric pain four days
ago. She has been sent home after excluding the acute
abdominal illness. As she still had had troubles, she was
examined at the general internal out-patient department. The
ECG revealed regular narrow QRS complex tachycardia with
long RP interval and frequency 156/min (Fig. 1). She was sent to
the Coronary Care Unit to perform a standard pharmacologicalPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
ocnice Podlesı´ a.s., Konska´ 453, 739 61 Trˇinec, Czech Republic.
om (K. Kluz).
a´meˇstı´ 133/2, Jejkov, 674 01, Trˇebı´cˇ, Czech Republic.
.
Fig. 1 – ECG presents narrow QRS complex tachycardia with long RP interval and heart rate 156/min.
Fig. 2 – Echocardiography record of parasternal long axis
(PLAX) the second day of the hospitalization: eccentric all
chamber dilatation, severe systolic dysfunction of the left
ventricle with LVEF 10%.
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tricular tachycardia).
Initial examination presented a patient in stable cardiopul-
monary condition, without serious clinical symptoms of a heart
disease. Blood pressure was 110/75 mmHg, heart rate 156/min.
The treatment was initiated with vagal manoeuvre—carotid
sinus massage. Arrhythmia persisted neither with a change
of the rate nor a blockade of atrio-ventricular conduction.
A pharmacological treatment was introduced as a next step.
Gradually increasing doses of adenosine were applied as a first
choice medication, with no effect on arrhythmia either.
Furthermore, verapamil was used. Administration of 5mg of
verapamil intravenously led to quick circulatory collapse with
severe hypotension and unconsciousness of the patient. Cardi-
opulmonary resuscitation (CPR) was initiated immediately, with
the need of intubation and mechanical ventilation, supramax-
imal doses of catecholamines were administered simulta-
neously. Supraventricular tachycardia was present during
all the time of CPR, with no response to any antiarrhythmic
drugs or repetitive attempts of electrical cardioversion. It took
more than 1 h of continual CPR, with use of mechanical chest
compression system (LUCAS), to restore a relative circulatory
stabilisation. Echocardiography revealed severe systolic dys-
function of the left ventricle with global hypocontractility and
ejection fraction of 10%, severe mitral and tricuspid regurgita-
tion due to dilation of the valvular annuli (Fig. 2). Finally, it was
intermittently possible to maintain sinus rhythm, after applica-
tion of further supramaximal dose of adenosine (18mg). Treat-
ment with amiodarone and digitalis was initiated subsequently.
The patient was extubated the next day, she had no neurolo-
gical dysfunction and she was in stable hemodynamic state,
with no further need for catecholamines. The diagnosis was
determined—tachycardia induced cardiomyopathy.
Only after extubation, when thorough history had been
taken, the patient confessed fatigue and dyspnoea at com-
mon exertion, which she attributed to her decondition and
common cold. Normal sinus rhythm was persisting ever
since, with only intermittent paroxysms of supraventricular
tachycardia during the treatment with amiodarone and
digoxin. Despite present sinus rhythm, there were still signs
of left ventricular dysfunction with global hypocontractility
and ejection fraction of the left ventricle of 45%. Because of
the prolongation of QT interval on ECG, amiodarone wasdiscontinued and magnesium was administered. Neverthe-
less, sustained ventricular tachycardia type torsades de
pointes occurred on the third hospitalization day, with the
need of external defibrillation and further antiarrhythmic
treatment.
Urgent electrophysiological study was indicated. Arrhyth-
mia was easily inducible with pacing manoeuvres, which
initially led to suspicion of re-entry type of tachycardia.
However, the focal origin of the arrhythmia was finally
proven. Focus mapping was performed with the use of
three-dimensional mapping system (CARTO), the focus was
localized in the right atrium, in parahisal position, approxi-
mately 6 mm distant from atrio-ventricular junction (Fig. 3).
After all the risks allied to the procedure had been weighed
up, radiofrequency ablation of the focus was successfully
performed. Stable sinus rhythm persisted after the proce-
dure, with no recurrence of supraventricular tachycardia. It
seemed that everything had been resolved to a happy end,
‘‘routine SVT’’.
The next day, during mobilization after the catheter
ablation procedure, the patient collapsed, but immediately
regained consciousness. A painful resistance in a right groin
occurred, in the puncture site after catheter ablation. An
Fig. 3 – Three-dimensional map of left and right atrium
(CARTO), the localization of the arrhythmia focus and place
of ablation is marked with red points. (For interpretation of
the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 4 – Echocardiography record of parasternal long axis
(PLAX) three months after dismissal of the patient: recovery
of the left ventricular function and diameters, LVEF 56%.
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femoralis communis, which was recompressed and the
patient was immobilized once again. Despite standard treat-
ment with low molecular weight heparin since the beginning
of the hospitalization, a right leg oedema appeared the next
day after immobilization. A duplex ultrasound study verified
deep vein thrombosis located in popliteal, femoral and iliac
vein. A conservative approach was chosen initially, as the
puncture of a great artery had been performed recently. The
low-molecular weight heparin was administered. However,
due to persistent pain and swelling of the whole right leg,
local thrombolysis of affected veins was performed. A com-
plete recanalization of the venous system was achieved with
slight residual post-thrombotic impairment of iliac and
femoral veins. Oral anticoagulation treatment was initiated.
A genetic study verified congenital thrombophilia (Factor V
Leiden and Factor II G20210A heterozygote mutation). Throm-
bophilia has certainly been potentiated by transdermal hor-
monal contraception used by the patient.
The patient was dismissed on the 24th day of hospitaliza-
tion at the Coronary Care Unit with six ‘‘new’’ diagnoses in
her twenties. She was cured by minimally 10 skilled physi-
cians, including cardiologists, an anaesthesiologist, an elec-
trophysiologist, an angiologist, a radiologist, a haematologist
and others. The price of the hospitalization was calculated to
425 778 Czech crowns.
A follow-up examination was performed three months
after the catheter ablation of the arrhythmia. It confirmed a
normalization of the left ventricular function with ejection
fraction of 56% and reduction of the mitral and tricuspid
regurgitation (Fig. 4). A duplex ultrasound study demon-
strated patent flow in the venous system of the right
lower limb. The patient was still treated with ACE inhibitor,beta-blocker and warfarin. She denied any problems, palpita-
tions nor dyspnoea on exertion.
Our last contact with this patient was 2 years after the
dramatic hospitalization, after that she left to study abroad,
without any medical troubles or residual impairment, with-
out any need for regular pharmacotherapy.3. Discussion
Symptoms of heart failure as dyspnoea and fatigue can be
underestimated, especially by young, healthy people. Tachy-
cardia induced cardiomyopathy is typically associated with
palpitations and continually worsening dyspnoea. This dis-
ease is caused by prolonged either supraventricular or ven-
tricular arrhythmia with fast ventricular rate in patients
usually without any overt structural heart disease.
Tachycardia induced cardiomyopathy may manifest months
to years after the onset of the responsible tachycardia and is
considered as potentially reversible state [1,2]. Hemodynamic
changes in this cardiomyopathy are complex and involve
dilation of heart chambers, reduced cardiac output, elevated
ventricular filling pressures, and elevated systemic vascular
resistance [1]. Neurohumoral activation is characterized by
elevation of brain natriuretic peptides, epinephrines, endothe-
lin-1, and activation of the renin–angiotensin–aldosterone sys-
tem [1,2]. Cellular changes involve microscopic transformation,
molecular and electrical changes.
The prognosis of the patients, as well as the extent of the
ventricular dysfunction, depend on the heart rate and on the
duration of the tachycardia. Elimination of the responsible
arrhythmia leads to left ventricular ejection fraction recovery
usually until one week, complete normalization of the ven-
tricular function is usually observed in four to six weeks.
However, diastolic dysfunction or microscopic changes can
persist permanently [3–5].
Focal atrial tachycardia is relatively rare arrhythmia and
reflects about 10% of all supraventricular arrhythmias. The
most common mechanism of this arrhythmia is abnormal
automaticity with the atrial rate of 120–220/min [6]. The
incidence of tachycardia induced cardiomyopathy in patients
with focal atrial tachycardia is about 10% [8]. Pharmacological
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 5 3 – e 4 5 6e456treatment of the arrhythmia is challenging in patients with
severe dysfunction of the left ventricle, as majority of avail-
able drugs have negative inotropic effects. The only feasible
agents are class III antiarrhythmics (amiodarone). Catheter
ablation of the focus, which can be located both in the right
and in the left atrium, could be the definitive and curative
treatment. The efficiency of this treatment is about 95% with
the risk of arrhythmia recurrence of about 10% [7–9].4. Conclusion
Prolonged palpitations and dyspnoea presented simulta-
neously should raise each primary-care physician’s attention
to possibility of cardiac dysfunction development. Cardiac
dysfunction can be well and long tolerated especially in
young people and heart failure symptoms can be under-
estimated. Early diagnosis of the tachycardia induced cardi-
omyopathy leads to significant improvement of one’s prognosis,
as the cardiac dysfunction is reversible after normalization of
the heart rate. The treatment of the patients is positive and
high-effective with contemporary possibility of invasive treat-
ment by catheter ablation of the arrhythmia.
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